Cyndeo Wealth Partners’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.52M Buy
+36,743
New +$1.48M 0.07% 223

Other funds holding FTXH

Cyndeo Wealth Partners's FTXH Position: Q3 2026 in Review

Cyndeo Wealth Partners opened a new position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q3 2026: 36,743 shares worth $1.52M. The stake represents 0.07% of the portfolio and ranks #223 among its holdings.

70 funds tracked by Wall St. Rank hold FTXH as of Q3 2026.

  • Cyndeo Wealth Partners held 36,743 shares of First Trust Nasdaq Pharmaceuticals ETF worth $1.52M as of Q3 2026.
  • First Trust Nasdaq Pharmaceuticals ETF was a new Cyndeo Wealth Partners position in Q3 2026.
  • First Trust Nasdaq Pharmaceuticals ETF made up 0.07% of Cyndeo Wealth Partners's portfolio in Q3 2026, its #223 holding.
  • 70 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2026.

Based on Cyndeo Wealth Partners's 13F filing for Q3 2026, filed 16 Oct 2026.